Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.
Arthritis and Rheumatism|January 1, 2008
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatmentMaxime Breban, Philippe Ravaud, Pascal Claudepierre, et al.
Joint Bone Spine|April 11, 2024
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiativeAdeline Ruyssen-Witrand, Damien Caillet-Portillo, Aurélie Najm, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Medicine|April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter studyHélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trialAnna Molto, Clementina López-Medina, Filip E Van den Bosch, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Rheumatology (Oxford, England)|November 3, 2021
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL studyJean-Guillaume Letarouilly, Thao Pham, Adeline Pierache, et al.
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.
Arthritis and Rheumatism|January 1, 2008
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatmentMaxime Breban, Philippe Ravaud, Pascal Claudepierre, et al.
Joint Bone Spine|April 11, 2024
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiativeAdeline Ruyssen-Witrand, Damien Caillet-Portillo, Aurélie Najm, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Medicine|April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter studyHélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trialAnna Molto, Clementina López-Medina, Filip E Van den Bosch, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Rheumatology (Oxford, England)|November 3, 2021
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL studyJean-Guillaume Letarouilly, Thao Pham, Adeline Pierache, et al.
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Pageof 16